In a report released today, Lauren Lieberman from Barclays maintained a Buy rating on Keurig Dr Pepper (KDP – Research Report), with a price ...
Analysts expect the Burlington, Massachusetts-based company to report quarterly earnings at 57 cents per share, up from 55 ...
Piper Sandler started coverage on Keurig Dr Pepper in a report on Tuesday, January 7th. They issued a “neutral” rating and a $35.00 price objective for the company. Finally, Barclays cut their ...
Lauren Lieberman from Barclays sets a price target of $36 for NASDAQ:KDP, indicating a potential upside of 5.51%. Q4 2024 ...
Keurig Dr Pepper Inc. (NASDAQ ... On January 17, Lauren Lieberman, analyst at Barclays maintained a Buy rating on the stock, while keeping the price target of $36. Oakmark Select Fund in its ...
On Jan. 17, Barclays PLC (BCS) reduced its price target for Keurig Dr Pepper to $36 from $39, while maintaining an “Overweight” rating on the stock. The analyst noted, "It feels like there ...
The top US merger banker last year was a woman. Meet her and 19 other dealmakers who dominated the M&A rebound, from Goldman ...
Keurig Dr Pepper, known for popular beverages such as Dr Pepper, Snapple, and the Keurig coffee system, operates in a highly competitive market with notable peers like Coca-Cola and PepsiCo. The ...